Chen, Y., Zhou, Y., Tang, L., Peng, X., Jiang, H., Wang, G., & Zhuang, W. (2019). Immune-Checkpoint Inhibitors as the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials. J Cancer.
Stile di citazione ChicagoChen, Yuqiao, Yuan Zhou, Lu Tang, Xiong Peng, Hong Jiang, Guo Wang, e Wei Zhuang. "Immune-Checkpoint Inhibitors As the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials." J Cancer 2019.
Citazione MLAChen, Yuqiao, et al. "Immune-Checkpoint Inhibitors As the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials." J Cancer 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.